Elucidation of the Effect of Brain Cortex Tetrapeptide Cortagen on Gene Expression in Mouse Heart by Microarray

This study used DNA microarray technology (gene expression chips) to broadly and unbiasedly map the effects of Cortagen on gene expression in mouse heart. The choice to analyze cardiac tissue (rather than brain tissue) was intentional — the objective was to demonstrate that bioregulatory peptides exert systemic effects beyond their tissue of origin.

Microarray analysis revealed that Cortagen modulated the expression of 110 known genes belonging to diverse functional categories, including:

• Structural and cytoskeletal genes (actin, myosin, tubulin)
• Cell signaling genes (kinases, phosphatases, receptors)
• Energy metabolism genes (mitochondrial enzymes, transporters)
• Stress response and apoptosis genes (heat shock proteins, caspase regulators)
• Transcription and translation genes (transcription factors, ribosomal proteins)

The breadth of the gene response was remarkable for a peptide of only 4 amino acids, challenging the conventional notion that short peptides would have limited biological activity. The authors proposed that Cortagen acts as an epigenetic modulator, influencing chromatin accessibility and gene transcription in a coordinated manner.

This work was one of the first to use high-throughput genomics to characterize the effects of peptide bioregulators, providing molecular evidence for the concept that short peptides can exert broad and coordinated gene regulation. The results suggest that Cortagen is not simply a neurotrophic factor, but a multifunctional regulator with systemic effects on gene expression.